GlassScriptPhysician profile
Arthur Jones
NPI 1053323980
$12,704.79
in general payments reported to CMS, 2019-2025
21 companies · $374 in 2025
The $374 reported for 2025 was more than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $441 · 2020: $667 · 2021: $21.95 · 2022: $39.07 · 2023: $11K · 2024: $454 · 2025: $374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,500 · Travel and Lodging: $1,584 · Food and Beverage: $1,451.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,500.00 |
| Travel and Lodging | $1,584.45 |
| Food and Beverage | $1,451.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,371.87 | 2023 | Davinci Xi, Da Vinci Surgical System |
| Olympus Corporation of The Americas | $927.77 | 2019-2020 | |
| Baxter Healthcare | $302.74 | 2024-2025 | Tisseel, Floseal |
| Sumitomo Pharma America, INC. | $197.48 | 2023-2025 | Myfembree, Gemtesa |
| Astellas Pharma US INC | $156.48 | 2024-2025 | Veozah |
| Organon LLC | $148.21 | 2022-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $93.35 | 2019-2025 | Gardasil, Gardasil 9 |
| Coopersurgical, INC. | $73.49 | 2023 | Endosee |
| Bayer Healthcare Pharmaceuticals INC. | $72.47 | 2019-2025 | |
| Evofem Biosciences, INC. | $60.91 | 2024-2025 | Solosec, Phexx, Phexxi |
| Exeltis, USA INC. | $55.23 | 2023-2024 | Slynd |
| Sage Therapeutics, LLC | $40.46 | 2024-2025 | Zurzuvae |
| Abbvie INC. | $39.79 | 2023 | |
| Allergan, INC. | $33.59 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $29.27 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $19.92 | 2023 | Interstim |
| Takeda Pharmaceuticals U.S.A., INC. | $17.57 | 2020 | |
| Mallinckrodt Enterprises LLC | $16.90 | 2019 | |
| Pfizer INC. | $16.70 | 2024 | |
| Amag Pharmaceuticals, INC. | $16.03 | 2019 | |
| Lupin INC. | $14.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.